Subsidies
Subsidies
subsidy
Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
---|---|---|---|---|---|---|---|
Identification of microproteins (MPs) to generate cancer vaccines. ALBA (Antigens for Liver and Breast Anticancer vaccines). | GOVERNMENT OF NAVARRA | University of Navarra | 2024 GN STRATEGIC PROJECTS OF RESEARCH AND DEVELOPMENT 2024-2027 | 12-06-2024 | 72.010,00€ | - | |
Chair University business (Chair CHIP): design microelectronic wireless battery-less sensors | TSI-069200-2023-0001 | Other national | University of Navarra | Chairs University-business "Chairs CHIP" | 07-05-2024 | 192.953,97€ | - |
IMPLEMENTATION OF THE DIGITAL RIGHTS CHARTER IN THE CREATION OF THE DIGITAL RIGHTS OBSERVATION SPACE | PUBLIC BUSINESS ENTITY NETWORK.ES, M.P. | University of Navarra | 2023 NETWORK.EN | 03-04-2024 | 64.000,00€ | - | |
Sustainable functional materials for 3D printing from Recycled oriGen for the Electrochemical sector (3DGREEN) | KK-2024/00009 | EUSKO JAURLARITZA - BASQUE GOVERNMENT | University of Navarra | ELKARTEK 2024 research Projects with high industrial potential | 01-04-2024 | 74.390,00€ | - |
INNOVATIVE FILTrado solutions based on non-invasive elements (INNOFILT) | KK-2024/00098 | EUSKO JAURLARITZA - BASQUE GOVERNMENT | University of Navarra | ELKARTEK 2024 research Projects with high industrial potential | 01-04-2024 | 61.160,70€ | - |
PORTRAIT. A multi-omic stratification and a non-invasive tool for early recognition of triple negative and Her2+ breast cancer patients responders to neoadjuvant therapy. | 0011-2750-2022-000000 | GOVERNMENT OF NAVARRA | University of Navarra | 2022 GN ERA PERMED | 22-03-2024 | 311.184,00€ | - |
EMPOWERED, INNOVATIVE AND ENTERPRISING 21ST CENTURY FORESTS | BF217 | BIODIVERSITY FOUNDATION | University of Navarra | 2023 FD Biodiversity. Projects for the promotion of the bioeconomy and contribution to the ecological transition. | 08-02-2024 | 118.361,00€ | MRR Funds |
Advancing Additive Manufacturing of Metallic Components high performing : Ecodesign and Environmental Impact assessment (ADDILANZA) | AQUITAINE-EUSKADI-NAVARRE EUROREGION | University of Navarra | EUROREGIONAL INNOVATION 2023 | 01-01-2024 | 18.500,00€ | - | |
INC-STEP | EUROPEAN COMMISSION | University of Navarra | Third Party Project Grant Contract (3PP Contract) under the TETTRIs Project (Grant Agreement N° 101081903) | 01-01-2024 | 38.214,68€ | - | |
Projection Methods for Device Error Mitigation (ZNEProDEM) | EUSKO JAURLARITZA - BASQUE GOVERNMENT | University of Navarra | Ikur Strategy IBM Projects | 01-01-2024 | 52.258,00€ | - | |
agreement DIPC-TECNUN - Quantum Technologies Line | DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC | University of Navarra | Quantum Technologies Line | 01-01-2024 | 96.194,50€ | - | |
Ikerbasque Permanent Position NAIARA RODRÍGUEZ FLÓREZ | IKERBASQUE BASQUE FOUNDATION FOR SCIENCE | University of Navarra | Permanent Positions 2023 IKERBASQUE | 01-01-2024 | 42.788,17€ | - | |
INTELLIGENT PLATFORM and CYBERSEGURE FOR ADAPTIVE OPTIMIZATION IN SIMULTANEOUS OPERATION OF AUTONOMOUS ROBOTS HETEROGENEOUS | PLEC2023-010353 | STATE INVESTIGATION AGENCY | University of Navarra | 2023 AEI Transmissions (CDTI) | 22-12-2023 | 345.582,00€ | MRR Funds |
Human flourishing to prevent depression: longitudinal analysis of the SUN cohort. | PI23/01332 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2023 AES Projects research | 20-12-2023 | 97.903,99€ | ERDF funds |
Dissecting the Role of the Immune Microenvironment in Myelodysplastic Syndromes. | RYC2022-036673--I | STATE INVESTIGATION AGENCY | University of Navarra | 2022 AEI RAMÓN Y CAJAL | 20-12-2023 | 314.350,00€ | ESF Funds |
Deciphering the mechanisms of resistance to radiotherapy in lung cancer. New opportunities for radiosensitizing therapies (RYC2022-038084-I). | RYC2022-038084-I | STATE INVESTIGATION AGENCY | University of Navarra | 2022 AEI RAMÓN Y CAJAL | 20-12-2023 | 244.350,00€ | MRR Funds |
essay Phase I clinical trial of a new antifibrinolytic agent, compound CM-352, with an efficient synthesis route, aimed at the control of disabling and lethal bleeding. | CPP2022-009643 | STATE INVESTIGATION AGENCY | University of Navarra | 2022 AEI PARTNERSHIP PUBLIC PRIVATE | 18-12-2023 | 1.161.431,98€ | MRR Funds |
assessment ultra-sensitive and minimally invasive myeloid neoplasms by integrated single-cell techniques | PI23/01331 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2023 AES Projects research | 18-12-2023 | 240.000,00€ | ERDF funds |
development of a new tool for the prediction of premature mortality based on lifestyle, cognitive function and molecular biomarkers of aging. | GN19/2023 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2023 GN Projects of research in health | 18-12-2023 | 77.510,00€ | - |
Human bioengineering for the detection and analysis of cardiovascular toxicity secondary to anti-oncology therapies. Sex factor analysis. | GN32/2023 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2023 GN Projects of research in health | 18-12-2023 | 79.925,00€ | - |